Market Size (2015)
2015
$915.00M
Healthcare
Amniotic Membrane Market
By Segment, By Region, And Segment Forecasts, 2015 – 2023
Vertical: HealthcareBase Year: 201712 Sections
Executive Summary
Amniotic Membrane Market — Snapshot
Projected (2023)
2023
$2.11B
CAGR (2015–2023)
11.0%
11.0%Key Players
104+
Amniotic membrane is a combination of tissues and cells which helps in wound healing by acting as foundation for re-growth of soft tissues. These are most widely used in eye surgery as a biological bandage to heal or replace damaged eye tissue. Increasing aging patient population, the rise in amniotic membrane-based transplantations globally, and rising disease awareness drive the growth of the global amniotic membrane market. However, stringent regulatory policies may hamper the growth of the market.
The global amniotic membrane market is expected to register a CAGR of 12.16% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with 37.6% share, followed by Europe and Asia-Pacific with shares of 31.9% and 23.4%, respectively.
The global amniotic membrane market has been segmented based on the type, application, end user, and region.
Based on the type, the cryopreservation amniotic membrane segment accounted for the largest market share of 56.5% in 2017, with a market value of USD 609.44 million, which is projected to register a CAGR of 10.44% during the forecast period.
Based on application, the surgical wounds segment accounted for the largest market share of 21.8% in 2017, with a market value of USD 235.58 million, which is projected to register a CAGR of 12.47% during the forecast period.
Based on end user, the hospital & clinics segment accounted for the largest market share of 38.9% in 2017, with a market value of USD 420.25 million, which is projected to register a CAGR of 13.39% during the forecast period.
Key Insight
The Amniotic Membrane Market market is projected to grow at a CAGR of 11.0% from 2015 to 2023.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: Middle East and Africa, Americas, Asia Pacific, Europe.
- Market Segmentation: The market is analyzed across 2 segments: Cryopreservation Amniotic Membrane, Lyophilized Amniotic Membrane. Forecasts are provided for each segment from 2015 to 2023.
- Competitive Landscape: 104 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Amniotic Membrane Market — Growth Trajectory
Amniotic membrane is the innermost layer of the placenta, and it consists of thick basement membrane and avascular stromal matrix. Amniotic membrane is used as a dressing in different surgical procedures. In the field of ophthalmology, this is used as tissue bandage for cornea infections and to reconstruct ocular surfaces for various procedures. Moreover, increasing awareness regarding the benefit of amniotic membrane in individuals as well as healthcare professionals will create more demand for amniotic membrane products. Hence it helps to boost the growth of the global amniotic membrane market.
Amniotic Membrane Market — Growth Trajectory
Cryopreservation Amniotic Membrane
Lyophilized Amniotic Membrane
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Type Type is broken down into: Cryopreservation Amniotic Membrane, Lyophilized Amniotic Membrane.
- Application Application is broken down into: Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Prenatal Diagnosis, Others.
- End User End User is broken down into: Hospital & Clinics, Ambulatory Surgical Centers, Research Centers and Laboratory, End User_Others.
Geographic Analysis
Regional market breakdown
- Middle East and Africa Middle East and Africa market size reached $64.97M in 2015 and is projected to reach $151.97M by 2023, growing at a CAGR of 11.2%.
- Americas Americas market size reached $348.62M in 2015 and is projected to reach $759.61M by 2023, growing at a CAGR of 10.2%.
- Asia Pacific Asia Pacific market size reached $210.45M in 2015 and is projected to reach $521.02M by 2023, growing at a CAGR of 12.0%.
- Europe Europe market size reached $290.97M in 2015 and is projected to reach $681.71M by 2023, growing at a CAGR of 11.2%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Amniotic Membrane Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2017
Historical Period
2015 – 2017
Forecast Period
2017 – 2023
Primary Interviews
150+
Research Process
Historical data (2015–2017) and forecast period (2017–2023)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Amniotic Membrane Market — Competitive Analysis
Bargaining Power of Suppliers
Bargaining power of suppliers in the global amniotic membrane market is medium. The suppliers in the global amniotic membrane industry are the hospitals and specialty clinics that derive amniotic membrane from the placenta of the fetus. Currently, a moderate number of suppliers are present in the market due to stringent government regulations and high opportunities. Currently, major players are accounting for a significant share of the market. Switching cost of the suppliers is medium because suppliers tend to enter into long-term associations, partnership, and deals with the companies that sell products made using amniotic membranes.
Bargaining Power of Buyers
The bargaining power of the buyers is medium in the global amniotic membrane market due to the presence of a moderate number of providers of amniotic membrane-based products. Also, the market has a large number of buyers comprising hospitals, clinics, ambulatory surgical centers, and other specialty clinics. Also, buyers prefer products manufactured by known brands. However, there are very few big brands present in the market. Because of this, the bargaining power of the buyers is medium.
Threat of New Entrants
The threat of new entrants in the global amniotic membrane market is medium. Any company trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. The market is also characterized by a high degree of brand loyalty where establishing a brand name is difficult for newcomers. Moreover, if a company desires to survive in the market, they have to introduce innovative products for various therapeutic applications and product innovation requires a large amount of investment as well as time. Also, there are very strict government regulations which a company has to follow in the market. However, the presence of huge opportunities in the market has increased the threat of new entrants to the market.
Threat of Substitutes
The threat of substitutes in the global amniotic membrane market is low to medium. Currently, amniotic membranes do not have any direct substitutes. However, stem cell technology can be used in a few of the application areas of amniotic membranes. Hence, the threat of substitutes is low to medium in the amniotic membrane market, due to very less availability of options in the market.
Intense Rivalry
The degree of competition in the global amniotic membrane market is medium. Many companies are present in this market. These players have a moderate degree of product differentiation. They are introducing innovative and more affordable products in the market. These factors slightly increase the rivalry in the amniotic membrane market. Companies involved in amniotic membrane market are trying to acquire new players in the market and merge with major players to survive in the market. Big brands are trying to acquire small players of the market, to create a competitive edge, which is creating a medium level of rivalry in the market.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Amniotic Membrane Market.
Regional Market Size (USD Mn)
Market estimates by geography (2023)
USD Mn
InsightAmericas leads with $759.61M by 2023, while Asia Pacific is projected to grow fastest at a 12.0% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $64.97M | $93.40M | $151.97M | 11.2% | 7% |
| Americas | $348.62M | $487.90M | $759.61M | 10.2% | 36% |
| Asia Pacific | $210.45M | $312.82M | $521.02M | 12.0% | 25% |
| Europe | $290.97M | $421.16M | $681.71M | 11.2% | 32% |
| Total | $915.01M | $1.32B | $2.11B | 11.0% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSegment Revenue (2023)
Cryopreservation Amniotic Membrane
Lyophilized Amniotic Membrane
03006009001200
Segment Market Share
- Cryopreservation Amniotic Membrane52%
- Lyophilized Amniotic Membrane48%
Total Market Size
$2.11B
Market by Segment (2023)
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Cryopreservation Amniotic Membrane | $1.09B | 11.0% | 66% |
| Lyophilized Amniotic Membrane | $1.02B | 11.0% | 73% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Amniotic Membrane Market — Key Findings
Analytical insights on Amniotic Membrane Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Amniotic Membrane Market market is projected to reach $2.11B by 2023, growing at 11.0% CAGR. The Cryopreservation Amniotic Membrane segment holds the largest share.
Market Dynamics
Amniotic membrane is a combination of tissues and cells which are used for biological dressing and helps in wound healing. It has anti-inflammatory, anti-bacterial, anti-immunogenic, and anti-fibrotic properties. In the early 1900s, the human placental membrane was used as a skin substitute. The amniotic membrane was first used in ophthalmology in 1940 for the treatment of ocular burn wound. Over the last 25 years, thousands of ocular surgical procedures were carried out with the help of the amniotic membrane to treat various ocular disorders. These are used in various surgical procedures as a biological dressing. These amniotic membranes are used in numerous surgical procedures such as biological bandages for burns, non-healing diabetic and venous ulcers, and repair of the abdominal hernia. The amniotic membrane is also used in eye surgeries as a biological bandage to heal damaged tissues. Over 2 million people worldwide receive treatments with amniotic membrane transplant for eye surgeries. However, factors such as the rising amniotic membrane transplantation and rapid growth in the geriatric population may hamper the growth of the market during the forecast period.
Market Drivers
Amniotic membrane is a biological tissue that is used as a graft for corneal and conjunctival reconstruction in various ocular surface diseases. It possesses anti-scarring and anti-inflammatory properties. The amniotic membrane is also used as a biological patch, bandage, and is also used to treat acute inflammatory disorders. As per the survey carried out by the National Centre for Biotechnology Information (NCBI) in 2016, a total of 771 amniotic membrane surgeries were performed in 2016 at the University Eye Hospital Tübingen. The overall prevalence of eye disease is approximately 14% in the general population. Pterygium is a wing-shaped superficial overgrowth on the ocular surface which is characterized by inflammation and invasion of the corneal surface. Whereas, the pterygium disease is common among adults in the US. A significant increase in amniotic membrane transplantation had been observed from 2001 to 2016. As per the Center of Ophthalmology Report 2016, the mean number of amniotic membrane transplantation was 48 per year. Moreover, increasing efforts by manufacturers on R&D activities to expand the product portfolio to include injections, pre-filled syringes, and medicines to meet the rising demand for amniotic membrane are some of the factors expected to drive the revenue growth of the target market.
Market Opportunities
Developing economies pose an opportunity for various markets as they have undeveloped research and development sectors owing to which they are unable to address upcoming health challenges. Despite huge demand, the African region is dependent on imported medicines and other health technologies. Although there is a high requirement for treatment, poor economic conditions lead to the slow growth of the healthcare industry within the African region. As per the statistics of NCBI in 2016, around 180 patients from West China Hospital who underwent excision of skin lesions treated with the help of amniotic membrane lived in low- and middle-income countries. This huge population affected with the ocular disease in developing countries serves as a strong opportunity for key players operating in the amniotic membrane market.
Market Restraints
Amniotic membrane is used for many years as an adjuvant for tissues healing. Its use has been continued to expand to other fields of orthopedics, urology, gynecology, plastic surgery, dentistry, and wound care. But these are most widely used in ocular surgery. The high cost of amniotic membrane remains one of the major barriers in the successful treatment of ocular diseases. The cost of the treatment increases exponentially with the increasing demand for an amniotic membrane for the treatment of various ocular diseases. The venous ulcers treatment costs even higher than other ocular diseases. Furthermore, healthcare reengineering paradigms that manage increasing co-morbidities such as skin disease, diabetes, and dry eye disease should offer additional potential for cost reductions in the coming years.
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Market Value by Segment (2023)
Value (USD Mn)
Cryopreservation Amniotic Membrane
Lyophilized Amniotic Membrane
Companies
Key companies profiled in Amniotic Membrane Market
Profiles of 104 companies operating in the Amniotic Membrane Market market, including revenue, employee count, and market positioning where available.
Showing 104 of 104 companies
MiMedx
MiMedx
Healthcare
Company Headquarters: Georgia, US Founded: 2008 Workforce: 1000+ Company Working: MiMedx is a biopharmaceutical company which develops, manufactures, and markets regenerative biologics using human placental allografts for multiple sectors of healthcare. The company processes human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce safe and effective allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx’s portfolio includes products based on amniotic membrane, umbilical cord, placental ECM, and amniotic fluid.
RevenueN/A
Employees1,000
Market CapN/A
Founded2007
Georgia, US
Skye Biolo
Skye Biologics Inc
Healthcare
Company Headquarters: California, U.S. Founded: 2006 Workforce: 200+ Company Working: Skye Biologics Inc. (Skye) develops and manufactures Biological Extracellular Matrix (BioECM) products designed to assist the body in its natural ability to remodel properly. These products are formulated to protect and augment degenerated or damaged tissues in surgical repairs and non-operative therapy as a potential alternative to surgery.
RevenueN/A
Employees200
Market CapN/A
Founded2005
California, U.S.
Applied Bi
Applied Biologics
Healthcare
Company Headquarters: Arizona, US Founded: 2010 Company Working: Applied Biologics is a manufacturer of wound care products which are derived from amnion. It is a fully integrated life sciences company that provides research, product development, manufacturing and distribution of medical technologies. It is an outstanding worldwide source of regenerative medicine technology, clinical research, education, and training for the constantly evolving healthcare industry. Its sole focus is on products based on amniotic membranes.
RevenueN/A
EmployeesN/A
Market CapN/A
Founded2009
Arizona, US
Integra Li
Integra LifeSciences Corporation
Healthcare
Company Headquarters: New Jersey, US Founded: 1989 Workforce: ~4,500 Company Working: Integra LifeSciences Holdings Corporation (Integra) is a world leader in medical technology. It offers innovative solutions for orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive & general surgery. Integra offers a broad portfolio of brands that include AmnioExcel, Bactiseal, Cadence, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, Salto Talaris, SurgiMend, TCC-EZ, Titan, and VersaTru. It sells its products through two business segments, namely, Codman specialty surgical and orthopedics and tissue technologies. It recently acquired one of the leading players of the global amniotic membrane market, Derma Sciences Inc. (US), a tissue regeneration company. Integra provides its innovative healthcare solutions in over 130 countries through more than 50 offices and worldwide distribution networks.
Revenue$1.0B
Employees4,500
Market CapN/A
Founded1988
New Jersey, US
Novavax, I
Novavax, Inc.
Healthcare
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Revenue$0.5B
Employees2,500
Market CapN/A
Founded1986
Maryland, US
Ology Bios
Ology Bioservices, Inc
Healthcare
Company Headquarters: Florida, US Founded: 1999 Workforce: ~800 Company Working: Ology Bioservices, Inc. is an integrated biopharmaceutical company that develops and manufactures biopharmaceuticals and medical devices. It specializes in cell therapy, gene therapy, viral vectors, antibodies, oncolytic viruses, biopharmaceutical manufacturing, and vaccines. It has collaboration and partnerships with recognized government agencies, namely the Department of Defense and Medical Countermeasures Advanced Development and Manufacturing, which support it in developing biodefense products. Moreover, it has decades of experience in developing, licensing, and manufacturing proteins, therapeutics, and vaccines. It develops products to offer both commercial customers and US governments. Furthermore, it is a wholly owned company of National Resilience, Inc. (US), and assisting Resilience through its services includes regulatory support from preclinical through licensure and cGMP manufacturing up to biosafety level 3 (BSL3).
RevenueN/A
Employees800
Market CapN/A
Founded1998
Florida, US
Page 1 of 18
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Amniotic Membrane Market
Starting from
$4,950